Major Surgical or Invasive Procedure: CVL placement Bone Marrow Biopsy Bronchoscopy Endotracheal intubation Tracheostomy PEG tube placement .
She was started on Zosyn and was transferred to [**Hospital1 18**] for direct admission for possible acute leukemia diagnosis.
Left breast cancer, diagnosed in [**2160**], s/p lumpectomy, XRT, and chemotherapy (please see below in oncologic history for details) 2.
History of tumor on spine 4.
Osteoporosis 5. s/p tonsillectomy/adenoidectomy 6. s/p L knee replacement 7. s/p ORIF of femur and fusion of ankle s/p fracture [**2154**] 8.
Multiple foot surgeries and an ankle fusion done for post-polio syndrome 9.
An ultrasound confirmed that the mass was solid, and an U/S guided biopsy found a 3.7 cm grade 3 infiltrating left ductal cancer with clean lymph nodes, ER positive, HER-2/neu negative, and negative LVI.
She received Cytoxan and Adriamycin x 4 and was on Femara for 4 years.
She was switched to tamoxifen in [**2166-2-23**] due to bone density thinning.
Menarche at age 11 with menopause in early 50's.
Took OCPs for approximately 3 years in the past and had been on estrogen for ~ 10 years but has stopped this.
Physical Exam: Vitals - T:101.7 BP: 150/71 HR: 105 RR: 22 02 sat: 96% RA/ 97% 2LNC GENERAL: fatigued appearing, non-diaphoretic, nad SKIN:  clammy, no rashes HEENT: no scleral icterus CARDIAC: tachy, no r/g LUNG: left mid-lung with crackles, no wheezes or rhonchi ABDOMEN:  soft, nontender, nondistended EXT: brace right lower ext; no edema bilaterally   Pertinent Results: OUTSIDE HOSPITAL LABS: ======================= ([**2166-12-31**] )NA 139 K 3.3 Cl 107 CO2 22 BUN 16 Cr 0.46 Glu 122 Ca 8.5 WBC 2.3  HCT 23  PLT 84 U/A: 0 gluc, 0 bili, 150 ketones, spgrav 1.031, pH 6  prot 100, nitrites neg, leukocytes neg; WBC [**11-28**]; RBC [**11-27**]; bacteria present .
POTASSIUM HYDROXIDE PREPARATION (Final [**2167-1-3**]):       WORK-UP PER DR.[**First Name (STitle) **],[**First Name3 (LF) **] PAGER [**Numeric Identifier 26242**] [**2167-1-5**].
POTASSIUM HYDROXIDE PREPARATION (Final [**2167-1-28**]):       Test cancelled by laboratory.
They also appear to co-express lymphoid associated antigen CD19 (dim, subset), but lack other B- and T-cell associated antigens, are CD10 (cALLa) negative, and are negative for CD56 and glycophorin A.
Right IJ catheter tip remains in the proximal right atrium.
Tip of the right jugular line projects over the superior cavoatrial junction.
A right IJ central venous catheter terminates at the cavoatrial junction.
A right IJ central venous catheter terminates at the cavoatrial junction.
[**2167-2-18**] CT chest: IMPRESSION: Minimal increase of parenchymal opacities, minimal increase of ground-glass opacities.
She was started on continuous IVFs, allopurinol prophylaxis, and DIC and TLS labs were monitored frequently.
She was not started on chemotherapy until her pneumonia improved.
No further treatment was pursued during this hospitalization due to her unstable clinical status (see below).
In the setting of neutropenia, she was started on cefepime and levofloxacin for CAP.
ID was consulted, who recommended starting Ambisome in addition to the cefepime.
Her fever curve began to trend down, and she was switched to PO voriconazole.
CT chest on [**1-8**] revealed decreased LUL opacity but more tree-and-[**Male First Name (un) 239**] opacities, likely secondary to pulmonary edema (given that the patient had gained >15 pounds while on continuous fluids).
She was started on vancomycin for persistent FN.
She was understanding of the risks but stated she preferred broad spectrum antibiotics and did not want to repeat the procedure.
Her cefepime was changed to meropenem to cover a possible Nocardial or anaerobic infection and levaquin was added for additional atypical coverage.
The evening following bronschocopy she required a NRB and attempts to wean with diuresis failed.
Meropenem and vancomycin were discontinued for concern for drug fever with new rash on lower extremities with no change in fever curve or rash.
All antibiotics were eventually discontinued for concern of drug fever.. She had reimaging of her chest, as well as her abdomen and head.
She was treated for a 7 day course of vancomycin (7 days from the day the culture positive line was pulled, [**Date range (1) 23062**]).
Through the course of the week, her vent was weaned, and she first tolerated trach collar on [**2-24**], and then remained off the ventilator starting [**2-25**].
A PMV valve was placed for assistance with speaking.
Given her worsening respiratory status, she was diuresed with IV lasix.
Following intubation she received IV fluid boluses.
A temporary HD catheter was placed and she remained HD dependent.
# Incontinence: Due to the patient's history of stress incontinence, a Foley was inserted during chemotherapy.
After chemotherapy, the Foley was removed, and she was started on oxybutynin.
Wound consult was also obtained for skin breakdown/irritation in her perineal area.
Her oxybutynin was discontinued as her renal function worsened and foley was placed to monitor output.
# Nutrition: Patient had a PEG placed for nutritional support.
She is getting tube feeds as outlined in discharge paperwork.
Medications on Admission: Alendronate-Vitamin D3 [Fosamax Plus D] Tamoxifen 20 mg Tablet 1 tablet daily B Complex Vitamins [B Complex] Calcium-Cholecalciferol (D3) [CALCIUM 500+D] Multivitamin with Iron-Mineral [Centrum] Omega-3 Fatty Acids [Fish Oil]  Discharge Medications: 1.
Lansoprazole 30 mg Tablet,Rapid Dissolve, DR [**Last Name (STitle) **]: One (1) Tablet,Rapid Dissolve, DR [**Last Name (STitle) **] DAILY (Daily).
Insulin Lispro 100 unit/mL Solution [**Last Name (STitle) **]: As directed, per sliding scale.
Heparin (Porcine) 5,000 unit/mL Solution [**Last Name (STitle) **]: One (1) Injection TID (3 times a day).
Acetaminophen 325 mg Tablet [**Last Name (STitle) **]: 1-2 Tablets PO Q6H (every 6 hours) as needed.
Clotrimazole 1 % Cream [**Last Name (STitle) **]: One (1) Appl Topical [**Hospital1 **] (2 times a day) as needed.
Nystatin 100,000 unit/mL Suspension [**Hospital1 **]: Five (5) ML PO QID (4 times a day) as needed.
Lorazepam 0.5 mg Tablet [**Hospital1 **]: 0.5 Tablet PO Q8H (every 8 hours) as needed: Hold for sedation, RR <10.
Diltiazem HCl 90 mg Tablet [**Hospital1 **]: One (1) Tablet PO QID (4 times a day): Hold for sbp <100 .
Epoetin Alfa 3,000 unit/mL Solution [**Hospital1 **]: One (1)  Injection QMOWEFR ([**Hospital1 766**] -Wednesday-Friday).
Heparin Flush CVL  (100 units/ml) 1 ml IV DAILY:PRN 10ml NS followed by 1ml of 100 units/ml heparin (100 units heparin) each lumen QD and PRN.
Ondansetron 8 mg IV Q8H:PRN 12.
Metoclopramide 5 mg IV Q6H:PRN   Discharge Disposition: Extended Care  Facility: [**Hospital3 7**] & Rehab Center - [**Hospital1 8**]  Discharge Diagnosis: Primary diagnoses: - AML - Respiratory distress complicated by need for tracheostomy - Renal failure requiring dialysis Secondary diagnoses: - History of breast cancer - Staph bacteremia s/p treatment - ICU myopathy - Post-polio syndrome   Discharge Condition: Stable, oxygen saturation 99% on 40% trach mask.
You had a feeding tube and tracheostomy placed.
Please contact Dr. [**Last Name (STitle) **] or the doctors following [**Name5 (PTitle) **] at the rehabilitation facility, or go to the emergency room if you experience any fevers, chills, chest pain, difficulty breathing, abdominal pain, bleeding, or other concerning symptoms.
You may also need a repeat bone marrow biopsy in the future.
